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Abstract
Background: Phylogeographic composition of M. tuberculosis populations reveals associations between lineages and
human populations that might have implications for the development of strategies to control the disease. In Latin America,
lineage 4 or the Euro-American, is predominant with considerable variations among and within countries. In Colombia,
although few studies from specific localities have revealed differences in M. tuberculosis populations, there are still areas of
the country where this information is lacking, as is a comparison of Colombian isolates with those from the rest of the world.
Principal Findings: A total of 414 M. tuberculosis isolates from adult pulmonary tuberculosis cases from three Colombian
states were studied. Isolates were genotyped using IS6110-restriction fragment length polymorphism (RFLP), spoligotyping,
and 24-locus Mycobacterial interspersed repetitive units variable number tandem repeats (MIRU-VNTRs). SIT42 (LAM9) and
SIT62 (H1) represented 53.3% of isolates, followed by 8.21% SIT50 (H3), 5.07% SIT53 (T1), and 3.14% SIT727 (H1). Composite
spoligotyping and 24-locus MIRU- VNTR minimum spanning tree analysis suggest a recent expansion of SIT42 and SIT62
evolved originally from SIT53 (T1). The proportion of Haarlem sublineage (44.3%) was significantly higher than that in
neighboring countries. Associations were found between M. tuberculosis MDR and SIT45 (H1), as well as HIV-positive
serology with SIT727 (H1) and SIT53 (T1).
Conclusions: This study showed the population structure of M. tuberculosis in several regions from Colombia with a
dominance of the LAM and Haarlem sublineages, particularly in two major urban settings (Medellı́n and Cali). Dominant
spoligotypes were LAM9 (SIT 42) and Haarlem (SIT62). The proportion of the Haarlem sublineage was higher in Colombia
compared to that in neighboring countries, suggesting particular conditions of co-evolution with the corresponding human
population that favor the success of this sublineage.
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Introduction
Tuberculosis (TB) continues to be a challenge to control.
Although widespread and common efforts have had an impact in
achieving declining numbers in global incidence for the first time
in history, TB still causes 8.7 million new cases and 1.4 million
deaths per year [1].
The worldwide population structure of Mycobacterium tuberculosis
has been defined, linking specific lineages to human populations.
Using comparative genomics and large sequence polymorphisms
(LSPs), six phylogeographic lineages have been described and
associated with human populations around the world [2]. For
example, the East-Asian lineage is dominant in many countries of
the Far East, while the Indo-Oceanic lineage occurs all around the
Indian Ocean. The Euro-American lineage is clearly the most
frequent lineage in Europe and the Americas. The relationships
between these lineages and human populations are supported not
only by studies with isolates from around the world, but also by the
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tendency of each lineage to cause the disease in populations in
specific urban cosmopolitan settings [3–6].
Genotyping techniques based on repetitive elements such as
restriction fragment length polymorphism (RFLP) using IS6110
[7], spoligotyping of clustered repetitive interspersed short
palindromic repeats (CRISPR) [8], and mycobacterial inter-
spersed repetitive units variable number tandem repeats (MIRU-
VNTRs) [9], have been used to support epidemiological studies as
well as to define the population structure in M. tuberculosis [10–12].
Spoligotyping and MIRU-VNTR have replaced the standard
IS6110-RFLP due to the ease of implementation and standard-
ization, and the availability of international databases for making
comparisons [10,13,14]. These latter techniques have demonstrat-
ed a concordance with the assignation of major lineages as defined
by LSPs [15–17], despite being subject to convergent evolution
[18].
Colombia is the third most populated country in Latin America.
The country has nearly 47 million inhabitants and has changed
from being mainly a rural population at the beginning of the 20th
century to a mostly urban population in the 21th century. The
increase in urban population together with crowding and poor
living conditions in the outskirts of major cities maintain favorable
conditions for TB transmission. Despite the country’s efforts to
control the disease, the estimated incidence is 34 per 100,000
individuals in the population, corresponding to approximately
16,000 new cases per year [19], which poses a major task for the
public health control of the disease. The overall incidence of TB
for Colombia hides the dissimilarities between regions, reflecting
differences in control measures as well as differences in transmis-
sion dynamics. These situations in turn, should influence the
relationship established between human and M. tuberculosis
populations.
Several studies have demonstrated the distribution of M.
tuberculosis lineages and sublineages in Latin American countries,
confirming the overwhelming predominance of the Euro-Amer-
ican lineage but with considerable variation in the distribution of
sublineages or clades between and within countries [20–25]. In
Colombia, studies performed on few specific locations also show a
predominance of Euro-American lineages with differences among
localities [26,27].
The aim of this study was to further assess the distribution of M.
tuberculosis lineages and sublineages in Colombia and to gain a
better understanding of the dynamics of the disease. M. tuberculosis
isolates were obtained from patients with pulmonary tuberculosis
from three different regions of Colombia. All isolates were
genotyped by using IS6110-RFLP, spoligotyping, and 24-locus
MIRU-VNTR. Then, associations between the main M. tubercu-
losis sublineages and the demographic and epidemiologic charac-
teristics of patients were evaluated. The discriminatory power of
the different genotyping methods was also calculated.
Methods
Ethics statement
All study procedures were approved by the Ethics Review
Boards of the participating institutions who were in charge of
recruiting the patients: Universidad de Antioquia, Centro Inter-
nacional de Entrenamiento e Investigaciones Médicas, CIDEIM,
and Universidad del Cauca. All patients had a signed written
consent previously approved by the ethics committee. When
patients were less than 18 years old an informed written and
signed consent was obtained with the additional approval and sign
of one of the parents. All sign consents were kept in physical files
locked under the custody of principal investigators to maintain the
anonymity of patients. The study was also approved by regional
and local health authorities in: Antioquia state and Medellin city,
Valle del Cauca state and Cali city and Cauca state and Popayan
city.
Study population
M. tuberculosis isolates were obtained from index tuberculosis
patients belonging to three cohorts followed in three different cities
in Colombia (Medellı́n, Cali, and Popayan) from March 2005 to
2008. These patients were part of a previous study performed in
the same cities, were we studied factors associated with TB
transmission among household contacts of patients with pulmo-
nary tuberculosis [28].
Index cases were included consecutively from urban populations
in cohorts from Medellin and Cali, whereas the smallest cohort
included cases from Popayan as well as from smaller towns in
Cauca state. An index case was included if the patient was older
than 15 years and had at least one household contact as described
previously [28]. Index cases were initially diagnosed based on
clinical symptoms, signs, and chest-X rays, and confirmed by acid-
fast bacilli (AFB) sputum examination using the Zielh-Nelsen stain,
at the local health facility. A second sputum specimen was
processed and cultured at the research laboratory designated in
each city. Sputum samples were decontaminated with NaOH and
N-acetyl-L-cysteine [29], cultured on an MGIT system (MGIT
960H) and/or solid Lowenstein-Jensen (LJ) culture media.
Identification of AFB-positive cultures was performed by pheno-
typic methods such as niacin, nitrate and 68uC catalase tests [29].
Drug susceptibility testing for first line anti-TB drugs was
performed using the proportion method in LJ [29]. M. tuberculosis
isolates were frozen in 50% glycerol at 270uC until use. One
isolate obtained from one AFB-positive smear sputum per patient
was used for genotyping.
M. tuberculosis genotyping
Isolates were genotyped using spoligotyping, IS6110-RFLP, and
24-locus MIRU-VNTRs. For IS6110-RFLP genotyping, a stan-
dard protocol was used following international recommendations,
which included a DNA extraction protocol [7,30]. Spoligotyping
was performed following standard procedures [8], using a
commercial source for membranes and reagents (Isogen Life
Science, De Meern, the Netherlands).
MIRU-VNTR genotyping was performed using polymerase
chain reaction (PCR) amplification of a standard set of 24 MIRU-
VNTR loci with primers specific for the flanking regions of each
VNTR region, and the detection of amplified PCR products was
carried out by electrophoresis. From the gel images, the
corresponding MIRU-VNTR bands were interpreted as copy
numbers based on a reference table [9]. Two of the participating
laboratories took part of the first and second multicenter
proficiency studies of the Global Network for the Molecular
Surveillance of Tuberculosis using MIRU-VNTR genotyping
[31].
The role of participating laboratories was as follows: Myco-
bacteriology laboratory at University of Cauca in charge of
culturing and identifying M. tuberculosis from patients in Popayan
and surrounding towns (Cauca state). Mycobacteriology laborato-
ry at Cideim was in charge of culturing and identifying M.
tuberculosis from patients in Cali (Valle state) and performed 24-
locus MIRU-VNTR in those isolates. Mycobacteriology labora-
tory at National Institute of Health in Bogota was in charge of
performing drug susceptibility tests and genotyping by IS6110-
RFLP, spoligotyping and 24-locus MIRU-VNTR to isolates from
Cauca and Valle states. Mycobacteriology laboratory at CIB
M. tuberculosis Population in Colombian Patients
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performed culture and identification of isolates from patients from
Medellin (Antioquia state) as well as genotyping using IS6110-
RFLP, spoligotyping and 24-locus MIRU-VNTR.
Clustering analysis, allelic diversity, and discriminatory
power
IS6110-RFLP, spoligotyping, and 24-locus MIRU-VNTRs
results were analyzed using the BioNumerics software version
6.6 (Applied Maths. Sint-Martens-Latem, Belgium) to establish the
relationships between different isolates of M. tuberculosis. Patterns of
IS6110-RFLP were digitized and similarities were calculated using
the Dice coefficient. MIRU-VNTR and spoligotyping data were
entered as character type and analyzed using the categorical
coefficient. Similarity trees and dendrograms were calculated using
the unweighted pair group method with arithmetic averages
(UPGMA). A cluster was defined as two or more M. tuberculosis
isolates with identical patterns. The MIRU-VNTR allelic diversity
(h) at a given locus was calculated as h = 12g xi2 [(n/n21)], where
xi is the frequency of the ith allele at the locus and n is the number
of isolates [9,32]. To determine the discriminatory power (DP) of
each genotyping method or a combination thereof, the Hunter-
Gaston Discriminatory Index (HGDI) was calculated [33].
Minimum spanning trees (MST) were created using the
Bionumerics software (Version 6.60) to explore the evolutionary
relationship among spoligotyping and 24-locus MIRU-VNTR
isolates. Spoligoforest trees were drawn to determine the parent-
to-descendant spoligotypes in the group of isolates studied using
the Fruchterman-Reingold algorithm and a hierarchical layout
using the SpolTools software [http://www.emi.unsw.edu.au/
spolTools, [34]], and reshaped and colored using the GraphViz
software [http://www.graphviz.org].
Lineage assignation and comparison with an
international database
Spoligotypes in binary format were converted to an octal code
for comparison with the SITVIT2 proprietary database of Institut
Pasteur de la Guadeloupe, which is an updated version of the
previously released SpolDB4 and SITVITWEB databases [10,13].
At the time of the analysis, SITVIT2 contained genotyping
information on about 110.000 M. tuberculosis clinical isolates from
160 countries of origin. In this database, a Spoligotype Interna-
tional Type (SIT) represents a spoligotyping pattern shared by 2 or
more patient isolates, as opposed to ‘‘orphan,’’ which does not
match with another pattern in the SITVIT2 database. Major
phylogenetic clades were assigned according to spoligotype
signatures and using revised SpolDB4/SITVITWEB rules
[10,13]. The sublineage distribution in cities from this study was
also compared with those from two other cities of Colombia
(Buenaventura and Bogotá), for which data were available in the
SITVIT2 database. We also compared the distribution of the
predominant SITs in the present study with the available data for
3 neighboring countries (Venezuela, Brazil, and Peru) in the
SITVIT2 database.
Descriptive statistics were used to show the distribution of
lineages and SITs per cohort of patients. STATA version 12
(STATA Corp. USA) was used for statistical analysis. Association
of clades and SITs with demographic and epidemiological
characteristics (human immunodeficiency virus [HIV] serology,
sex), susceptibility to first-line drugs, and number of IS6110-RFLP
copies, as well as differences in distribution according to cohorts,
were calculated using Pearson’s Chi-square test when more than
80% of the data had values greater than 5 and Fisher’s Exact Test
for the remaining data with smaller values (where at least 20% of
data had values less than 5).
All study procedures and written consent forms were approved
by the Ethics Review Boards of the participating institutions.
Results
Four hundred and fourteen M. tuberculosis isolates were studied
from index cases included in three cohorts followed in three
different Colombian cities for a period of three years (2005 to
2008). The median age of the patients was 39.1 years (range 15 to
96 years), and 42.8% of them were female. Bacillus Calmette-
Guerin (BCG) vaccination was confirmed in 75.6% of patients and
1.8% were sero-positive for HIV. Most of the isolates (75.1%) were
pan-susceptible to anti-TB drugs, 12.1% exhibited some drug
resistance, and 4.6% were resistant to both isoniazid and rifampin
(multi-drug resistant, MDR).
A total of 84 spoligotypes were identified; these included 20
orphan patterns that have not yet been reported to the SITVIT2
database (Table 1). The other 64 patterns matched a preexisting
shared type in the database (50/64 SITs containing 374 isolates) or
created a new shared type (14/64 SITs containing 20 isolates)
within this study or after a match with a previously reported
orphan in the SITVIT2 database (Table 2). Furthermore, 25 out
of 64 pre-existing SITs containing 355 isolates were clustered (2 to
124 isolates per cluster), corresponding to 85.75% of all isolates.
The number of unclustered isolates was 59 (39 isolates with unique
SITs plus 20 orphan isolates) out of 414, or 14.25%.
SIT 42 (LAM9) with 124 isolates and SIT 62 (H1) with 97
isolates represented 29.9% and 23.4% of the total isolates,
respectively (Table 2). These two SITs accounted for 3.78% and
17.7% of the isolates when compared with the total number of
isolates in the SITVIT2 database, and together represented more
than 10% of the isolates in South America, North America, and
Southern Europe. In contrast, SIT207 (H3) with 8 isolates and
SIT727 (H1) with 13 isolates represented 25.8% and 34.2% of the
isolates in the SITVIT2 database; these SITs have been reported
mostly in South America and North America (Table 3, see also
table S3 for comparison of sublineages distribution with neigh-
boring countries).
MSTs were constructed based on spoligotype patterns and 24-
locus MIRU-VNTRs. Figure 1A shows MSTs based on
spoligotypes in which two major groups were evident and
belonged to the Haarlem and LAM sublineages, and included
most of the isolates (SIT62 and SIT42, respectively, were the most
frequent in these lineages). Other isolates were grouped as the ill-
defined T sublineage (with SIT 53 as the most frequent) and X
sublineage (with SIT91 as the most frequent). More distance was
evident among isolates that integrate with the Haarlem sublineage
than in those integrating with the LAM sublineage. In contrast,
when MSTs were constructed using 24-locus MIRU-VNTR,
isolates belonging to LAM appeared more distant than those
integrating with the Haarlem sublineage. However, 24-locus
MIRU-VNTRs better grouped isolates into major lineages such
as LAM, Haarlem, S, T, and X; unique isolates belonging to the
African sublineage and East African-Indian sublineage were
clearly separated (Figure 1B). MSTs combining spoligotyping
and MIRU-VNTR are shown in Figure 1C. There was agreement
in the manner in which every genotyping method grouped isolates
in the major sublineages. The 24-locus MIRU-VNTR analysis of
common SITs (SIT42, SIT62, and SIT50) clearly showed that
they are composed of very closely related isolates, which were
distinguished by only one or two allele changes. Spoligoforest trees
generated by means of the Fruchterman-Reingold algorithm and
M. tuberculosis Population in Colombian Patients
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hierarchical layout (Figure S2 A and B) confirmed the dominance
of SIT42 (LAM) and SIT62 (Haarlem). The SIT42 (LAM) cluster
was the largest node evolved from SIT53 (T1), from which
multiple spoligotypes arose. The second largest spoligotype SIT62
(H1) appears to derive originally from SIT53 (T1) and more
recently from SIT50 (H3), finally giving rise to a lower amount of
SITs.
An evolutionary MST based on spoligotypes as a function of
several associated characteristics showed significant differences
between predominant SITs (.2%) and drug resistance (unknown
not included) (p,0.001) (Figure S1). It is worth noting that all
strains belonging to SIT45 (H1) were MDR (6 out of 6). The
difference between predominant SITs (.2%) and the three higher
IS6110-RFLP copy number (8, 9, and 11 bands) was also
significant (p = 0.011). Significant differences were found between
predominant SITs and HIV-positive serology (p = 0.044). The
proportion of HIV-positive patients was greater among isolates
belonging to SIT727 (H1) (2 HIV-positive out of 13) and SIT53
(T1) (2 HIV-positive out of 19)(Figure S1). Unknown HIV-status
was not included in the analysis. No significant differences were
noted when comparing the sex ratios of all predominant SITs (p.
0.5).
The phylogeographical distribution of M. tuberculosis lineages
around Colombia is shown in Figure 2A. Our data showed that
LAM represented 39.6% of the isolates from Medellı́n (Antioquia
State), 39.1% of the isolates from Cali (Valle state) and 24.0% of
the isolates from several towns in Cauca state. The Haarlem
sublineage was found to comprise 48.7% of the group of isolates
from Medellı́n and 39.0% of the group of isolates from Cali, but
was not represented in isolates from Cauca. In contrast, the ill-
defined T sublineage makes up 40.0% of the isolates from Cauca,
including the town of Popayan (the main city), as compared to the
proportion of isolates from this sublineage in Medellı́n (6.4%) and
Cali (11.0%). No isolates belonging to Beijing sublineage were
identified in our study. Genotyping data available in the SITVIT2
database from other two cities in Colombia (Buenaventura and
Bogotá), showed a predominance of isolates belonging to the LAM
and Haarlem sublineages. Other lineages such as T, X, and S are
less represented in these two cities with the exception of the Beijing
sublineage which was frequent in the city of Buenaventura.
Figure 1. Minimum spanning tree (MST) illustrating evolutionary relationships between M. tuberculosis spoligotypes identified in
our study (A). MST constructed with spoligotyping. (B) MST constructed with 24-locus MIRU-VNTR (C) Composite MST with spoligotyping and MIRU-
VNTRs markers. MST were constructed on all isolates (n = 414, including 20 orphan patterns). The phylogenetic tree connects each genotype based
on degree of changes required to go from one allele to another. The structure of the tree is represented by branches (continuous vs. dashed and
dotted lines) and circles representing each individual pattern. Note that the length of the branches represents the distance between patterns while
the complexity of the lines (continuous, gray dashed and gray dotted) denotes the number of allele/spacer changes between two patterns: solid
lines, 1 or 2 or 3 changes (thicker ones indicate a single change, while the thinner ones indicate 2 or 3 changes); gray dashed lines represent 4
changes; and gray dotted lines represent 5 or more changes. The size of the circle is proportional to the total number of isolates in our study,
illustrating unique isolates (smaller nodes) versus clustered isolates (bigger nodes). The color of the circles indicates the phylogenetic lineage to
which the specific pattern belongs. Note that orphan patterns are circled in orange. Patterns colored in yellow indicate a strain with an unknown
signature (unclassified).
doi:10.1371/journal.pone.0093848.g001
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An MST based on spoligotypes and the state in which the
isolates were obtained (Figure 2B) revealed a close evolutionary
relationship with the main spoligotypes found in this study, which
were LAM (SIT42) and Haarlem sublineages (SIT62) mostly in
the states of Antioquia and Valle. In contrast, isolates from Cauca
state were more distantly related even among the most frequently
identified, the ill-defined T sublineage. The only exception was
SIT53 (T1), which was found in greater proportion in Cauca state
than in other areas of the country. Furthermore, the difference in
the sublineage distribution of isolates from the three states of the
country reported in this study was significant (p,0.001). The
analysis based on 24-locus MIRU-VNTR showed that 52.3% of
isolates from Medellin were grouped into 40 clusters (2 to 29
isolates per cluster), 9.4% of isolates from Cali were grouped into 3
clusters (2 isolates each) and 8% of isolates from Popayán and
surrounding towns were grouped in one cluster (2 isolates).
Comparative DP was calculated for the three genotyping
methods used in this study. The method with the highest DP
(0.9916) was 24-locus MIRU-VNTR, followed by IS6110-RFLP
(0.9868) and then spoligotyping (0.8414). The DP obtained using
the combination of the three genotyping methods was slightly
higher than that observed for 24-locus MIRU-VNTRs (0.9918 vs.
0.9916). We also evaluated different combinations of MIRU-
VNTRs and calculated their corresponding DP. Eight-locus
MIRU-VNTR with a allelic diversity greater than 0.6 showed a
discriminatory power of 0.9771, while 15-locus MIRU-VNTR
with the highest allelic diversity, showed a DP of 0.9855 slightly
above of the recommended set of 15-locus MIRU-VNTRs [35],
that showed a discriminatory power of 0.9847 (see Table S1). The
allelic diversity for the different MIRU-VNTR loci was evaluated
using Hunter-Gaston diversity analysis. Locus QUB11b showed
the greatest allelic diversity with a diversity index of 0.780 (CI
0.767–0.793), whereas locus 20 showed the lowest diversity index
0.033 (CI 0.009–0.056) (see Table S2).
Discussion
This study presents a phylogeographic panorama of the M.
tuberculosis population structure in Colombia. The isolates analyzed
Figure 2. Phylogeographical distribution of M. tuberculosis sublineages identified in our study and MST according to patients’
origin grouped by cities or states. (A) The Map shows the cities of our study and others with their corresponding pie representing the proportion
of M. tuberculosis sublineages; Distribution of sublineages among strains belonging to the 3 sites of study (Antioquia, Valle del Cauca and Cauca)
vs. strains contained in international database SITVIT2 for cities Bogota and Buenaventura. (B) MST illustrating evolutionary relationships between M.
tuberculosis spoligotypes in our study in function of states. The cities have been located into their corresponding states: Medellin is located in
Antioquia; Cali is located in Valle del Cauca; and Popayan, Caldono, Morales, El Tambo, and Piendamo are located in Cauca state. The map was
obtained from http://www.uxabilidad.com/recursos/mapa-politico-de-colombia-envectores.html which is available as a public domain.
doi:10.1371/journal.pone.0093848.g002
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from three states showed the LAM and Haarlem clades as being
dominant, grouping 82.8% of them mostly in urban settings
(Medellı́n and Cali cities). Other studies carried out in Colombia,
based on spoligotyping and deposited in the SITVIT2 database,
showed the same predominance of the Haarlem and LAM
sublineages. One of these studies was in Bogotá, the major urban
setting of Colombia, in which the proportion of the LAM,
Haarlem, and T clades were 49.3%, 25.0%, and 13.8%
respectively [26]. This study also reported SIT42 (LAM9),
SIT62 (H1), and SIT53 (T1) as the major clusters comprising
45.8% of isolates. By contrast, our present study showed the same
SITs (42, 62, 53) comprising 58.4% of isolates, of which SIT42
(LAM9) and SIT62 (H1) accounted for 53% of isolates.
The LAM, Haarlem, ill-defined T, X, and S sublineages belong
to the Euro-American lineage or lineage 4, one of the six major
lineages for M. tuberculosis that have been described around the
world [2,36,37]. This lineage, although present in several regions
of the world, is predominant in Europe and America. In Latin
America, this lineage is dominant and have been reported by
several studies with considerable variation among countries. In our
study 37.4% of isolates belonged to LAM. This sublineage
appeared to be most common in Brazil (46%), Venezuela (53%),
and Peru (28.3%). In the three countries that share borders with
Colombia, the proportion of Haarlem is quite variable; our data
shows a proportion of 41% among the studied isolates, in contrast
to those seen in Venezuela (5%), Brazil (12%), and Peru (28%)
[20–23,25].
When comparing the main SITs found in our study with their
frequencies in neighboring countries, there is a significant
difference in the proportion of SIT42 (LAM9): 29.9% for our
study versus 11.8% for Venezuela, 8.8% for Brazil, and 5.6% for
Peru (based on the SITVIT2 database). The differences are more
striking in the case of SIT62 (H1), which is one of the two most
endemic in Colombia, when compared to the same neighboring
countries, with 23.4% of isolates belonging to this SIT versus
0.53%, 0.02%, and 0.08% for Venezuela, Brazil, and Peru,
respectively (SITVIT2 database) (see Table S3).
Contrary to the sublineage distribution observed in isolates from
the main urban settings, those obtained from Cauca state were
grouped predominantly (40%) in the ill-defined T sublineage, with
no isolates belonging to Haarlem. The clear difference among the
distribution of sublineages in Cauca state compared to that in the
urban settings of Valle and Antioquia (Cali and Medellı́n) might be
explained by the smaller group of isolates studied, and by the
human origin of these isolates. Most of the cases from Cauca state
were from patients living in smaller urban and rural areas located
in the south of the country, which is characterized by a higher
proportion of indigenous population. These facts suggest differ-
ences in transmission conditions as well as host factors that
ultimately may affect the successful establishment of a particular
M. tuberculosis lineage in a given human population.
Analysis of M. tuberculosis isolates from Buenaventura city (Valle
state), a seaport in the South Pacific coast of Colombia, have
identified isolates belonging to the LAM and Haarlem sublineages,
but also isolates belonging to the Beijing sublineage (SITVIT2
database). This was an unusual finding compared to our study, in
which no Beijing isolates were identified. This sublineage,
although described for the first time in 1998 in this Colombian
seaport city, has only been reported since then from patients whose
origin is from this same city, or patients with the same origin but
diagnosed in the country’s inland major urban settings [38–40]. In
agreement with these data, despite the human migration from
Asia, where the Beijing isolates are very frequent, they represent a
proportion about 5% or less of isolates in Latin America,
according to several reports [20–25].
There was significant association between MDR-TB and HIV
status with particular spoligotypes. For example, six isolates
belonging to SIT45 (H1) were MDR. Analysis of these isolates
using 24-locus MIRU-VNTRs revealed that they were very closely
related, but only grouped four of them into two clusters. This
finding may represent a particular transmission focus, because all
were isolates from patients in Medellı́n, rather than showing a
particular predisposing trend of this spoligotype to develop as
MDR. No clear association has been found in terms of
predominant lineages or sublineages and MDR among different
studies in Latin America [25,41,42]. Despite this, the Beijing
sublineage has been associated with a high proportion of drug
resistant isolates in several parts of the world [43,44], including
Colombia [27]. Moreover, the M strain (Haarlem 2) has been
linked to large MDR-TB outbreaks in Argentina [45].
MST analysis provided a detailed picture of genetic distances
among M. tuberculosis isolates studied based on spoligotyping and
MIRUs. Using both genotyping methods facilitated a better
assignment of the major and dominant groups belonging to the
Euro-American sublineages LAM and Haarlem (lineage 4). This
was in agreement with previous studies that demonstrated the
utility of this approach in assigning clades and sublineages,
particularly within the Euro-American lineage [15]. The hierar-
chical layout and Fruchterman-Reingold analysis based on
spoligotyping interestingly showed that SIT42 (LAM9) and
SIT62 (H1), the more conspicuous SITs found in this study, were
derived initially from SIT 53 (T1) and lately evolved to the more
dominant type. The reason behind the expansion of these
particular SITs in the studied isolates and populations, over co-
existing non-dominant SITs, might suggest a conjunction of social
changes such as accelerated population growth in impoverished
sub-urban settings facilitating the transmission of the disease, with
mostly still unknown microbe characteristics that allowed the
adaptation of particular M. tuberculosis isolates to specific human
populations. An example of successful M. tuberculosis isolates in a
particular population was published recently, linking the success of
some of them to phenotypic characteristics such as slower growth
in monocytes and the ability to elicit a less inflammatory response
[46].
A more detailed look at the spoligotyping and 24-locus MIRU-
VNTRs composite MST for SIT42 (LAM9) and SIT62 (H1)
showed a MIRU-VNTR multiplicity of clusters: 12 clusters in
SIT62 and 15 clusters in SIT42, along with unique isolates. Most
isolates belonging to these two spoligotypes were very closely
related, since they were differentiated by one or two MIRU-
VNTR allele changes, supporting the notion that recent expansion
and evolution of these groups of isolates have occurred in
accordance with the rate of mutation calculated for MIRU-
VNTR [17]. The analysis based on 24-locus MIRU-VNTR
showed that there was a greater percentage of clustering in isolates
from Medellin (52.3%) than in Cali (9.4%) and Popayan and
surrounding towns (8.0%). This suggests a more active and
ongoing transmission in Medellı́n (the largest group of isolates
studied) than in the other two areas.
A practical utility of the major discriminatory power of the 24-
locus MIRU-VNTR set over spoligotyping and IS6110-RFLP is its
use as an epidemiological marker to distinguish between a diversity
of isolates, including those associated with specific transmission
chains. This is particularly useful in settings with high endemicity
and disease transmission, as observed in one of urban settings
studied. Supporting the epidemiological use of MIRU-VNTR in
the population studied is the finding that most of the clusters
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identified by this method were circumscribed to one of the two
urban centers studied. In addition, we found that MIRU23,
ETRB, and Mtub34, which are excluded from the recommended
15-locus MIRU-VNTR for epidemiological studies [35], had
allelic diversity index values higher than 0.5. This finding might
lead us to consider the use of these loci in different genotyping
studies, especially in areas with M. tuberculosis lineage distribution
similar to that observed in this study.
In summary, this study shows the distribution of M. tuberculosis
lineages and sublineages in several regions in Colombia, with an
important dominance of LAM and Haarlem belonging to lineage
4, particularly in two major urban settings (Medellı́n and Cali).
Two dominant spoligotypes were LAM9 (SIT42) and Haarlem1
(SIT62). The use of 24-locus MIRU-VNTR showed the best
discriminatory power and proved useful in epidemiological studies
in which the Euro-American lineage is prevalent. The proportion
of the Haarlem sublineage was higher in Colombia compared to
that in neighboring countries, suggesting the presence of particular
conditions of co-evolution with the corresponding human popu-
lation that favor the success of this sublineage.
Supporting Information
Figure S1 A minimum spanning tree (MST) illustrating
evolutionary relationships between the M. tuberculosis
spoligotypes in our study in function of studied param-
eters. (A) Drug resistance; (B) IS6110-RFLP; (C) HIV Serology;
(D) Sex ratio.Difference between predominant SITs (.2%)
including SIT45 vs. Drug resistance (Code 0 Unknown not
included) is very significant (p,0.001); note that all strains
belonging to SIT45/H1 are MDR. The difference between
predominant SITs.2% and the 3 Major IS6110 RFLP No of
Bands (8, 9 and 11) is significant (with a p-value = 0.011). The
difference between predominant SITs and HIV serology is
significant (p = 0.044), note that the proportion of HIV positive
patients is more visible among strains belonging to SIT727/H1
(number of HIV positive = 2/13) and SIT53/T1 (n = 2/19).
Missing HIV status values have not been taken into account. No
significance difference was observed when comparing sex ratios of
all predominant SITs (p value.0.5).
(TIF)
Figure S2 A representation of parent to descendant
spoligotypes within our study sample (n = 414 isolates)
as seen through Spoligoforest trees drawn using the
SpolTools software (available through http://www.emi.
unsw.edu.au/spolTools; Reyes et al. 2008), and re-
shaped and colored using the GraphViz software
(http://www.graphviz.org; J. Ellson et al. 2002). (A) Tree
drawn using Fruchterman Reingold algorithm (B) tree drawn
using a Hierarchical Layout. In both trees, each spoligotype
pattern from the study is represented by a node with area size
being proportional to the total number of isolates with that specific
pattern. Changes (loss of spacers) are represented by directed edges
between nodes, with the arrowheads pointing to descendant
spoligotypes. The heuristic used selects a single inbound edge with
a maximum weight using a Zipf model. Solid black lines link
patterns that are very similar, i.e., loss of one spacer only
(maximum weigh being 1.0), while dashed lines represent links of
weight comprised between 0.5 and 1, and dotted lines a weight less
than 0.5. Note that in both trees, SIT42/LAM9 is the biggest node
(n = 124, 29.95%), followed by SIT62/H1 (n = 97, 23.43%),
SIT50/H3 (n = 34, 8.21%), SIT53/T1 (n = 21, 5.07%) and
SIT727/H1 (n = 13, 3.14%), which are other predominant
patterns in our study. On the other hand, orphan isolates (double
circled), appear mostly at terminal positions on the tree, or are
isolated strains without interconnections with the other strains.
(TIF)
Table S1 Comparative discriminatory power of three genotyp-
ing methods used in 414 M. tuberculosis isolates from Colombia.
(DOCX)
Table S2 Allelic diversity using Hunter-Gaston Diversity index
for 24 MIRU-VNTR loci genotyping in 414 M. tuberculosis isolates
from Colombia.
(DOCX)
Table S3 Distribution of the proportion of predominant SITs in
study as compared to their distribution in neighboring countries
Venezuela (n = 935), Brazil (n = 4556), and Peru (n = 1296),
recorded in the SITVIT2 database.
(DOC)
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